STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Oruka Therapeutics, Inc.

Filed

March 2, 2026

Period of Report

March 2, 2026

Accession Number

0000907654-26-000022